NUCRYST Pharmaceuticals (NCST) Approves Stock Buyback Plan
More News related to NCST
- NUCRYST Announces Special Meeting of Shareholders
- Westaim announces 2009 third quarter results
- NUCRYST announces 2009 third quarter financial results
- Unusual 11 Mid-Day Movers 11/11: NCST, SMI, MSN, CHLN Higher; TONE, RHIE, CLWR, STV Lower
- Notable Mergers and Acquisitions of the Day 11/11: BIN/WSII, NCST/SNN, SYK/SURG, LOGI/LifeSize
More News related to Stock Buybacks
- Notable Late-Afternoon ETF Movers for 11/25: UNG, GDX, XRT Higher; UUP Lower
- Notable 52-Week High's and Low's: BMY, JCG, PBR, SLW, GOOG, INCY, NTAP, QADI, GOLD, BONT Higher; SPWRB Low
- Unusual 11 Mid-Day Movers 11/25: RTK, QADI, QBC, KBX Higher; BNHNA, DRAM, TBH, CWTR Lower
- Afternoon ETF Check: UNG, XRT, EWJ Up; VNM, RSX Down
- Notable Analyst Ratings Changes 11/25: EXXI, IWA, VPRT Upgraded; BNHN, NRG, GTE Downgraded
NUCRYST Pharmaceuticals (Nasdaq: NCST) has authorized a program for the company to repurchase up to 900,000 shares of its outstanding common stock for an amount not to exceed $1.3 million using the facilities of NASDAQ.
NUCRYST Pharmaceuticals Corp. develops, manufactures and commercializes medical products that fight infection and inflammation.[SM]
Related Categories
Stock BuybacksStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
